Showing results (51-60 of 236) with videos related to

Sort By:
Pageof 24
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2019
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumorsNicola Fazio, Chiara A Cella, Marzia Del Re, et al.
Journal of Neuroendocrinology|October 28, 2022
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysisGiulia Arrivi, Francesca Spada, Samuele Frassoni, et al.
International Journal of Molecular Sciences|February 13, 2026
Diagnostic and Therapeutic Challenges Related to HER2 Heterogeneity in Gastric Cancer: Bridging Molecular Pathology and Clinical Decision-MakingNelia Marina Rosanu, Lorenzo Gervaso, Renato Lobrano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2024
Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancerChiara Alessandra Cella, Benjamin Djulbegovic, Iztok Hozo, et al.
Ecancermedicalscience|December 11, 2012
Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumoursFrancesca Spada, Nicola Fazio, Guido Bonomo, et al.
Cancers|October 16, 2024
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine NeoplasmsCatarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Updates in Surgery|February 28, 2022
Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumorsEmilio Bertani, Fabio Zugni, Davide Radice, et al.
Current Oncology Reports|March 9, 2022
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to BedsideMaria João de Sousa, Lorenzo Gervaso, Monica Isabel Meneses-Medina, et al.
Pancreas|January 19, 2017
Everolimus in Pancreatic Neuroendocrine Carcinomas G3Francesco Panzuto, Maria Rinzivillo, Francesca Spada, et al.
Pageof 24